keyword
https://read.qxmd.com/read/38596423/evaluation-of-a-quality-improvement-process-for-health-system-retention-of-long-acting-growth-factors-prescriptions-in-the-pediatric-oncology-population
#1
JOURNAL ARTICLE
Alexis Hamelink, Joshua Elder, Kyle Harwood
OBJECTIVE: Granulocyte-colony stimulating factor (GCSF) products are often used in pediatric patients with malignant diagnoses to reduce the time that the patient is neutropenic. Long-acting GCSF products have been shown to be non-inferior to daily dosing of GCSF products, and are becoming more desired by patients and families. Insurance companies often require a prior authorization prior to approving the use of the long-acting GCSF products. This process has proven challenging leading to treatment delays and missed doses...
April 2024: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38538691/potential-diagnostic-and-drug-target-markers-in-glioblastoma
#2
JOURNAL ARTICLE
Hina Ahsan, Muhammad Asghar, Shaukat Iqbal Malik
Glioblastoma multiforme (GBM) IDH-wildtype is the most prevalent brain malignancy in adults. However, molecular mechanisms, which leads to GBM have not been completely elucidated. Granulocyte colony-stimulating factor (GCSF), Granulocyte colony-stimulating factor receptor GCSFR, and Signal transducers and activators of transcription 3 (STAT3) have been involved in the occurrence and development of various cancers, but their role in GBM is little known. Herein, we have investigated the gene and protein expression of GCSF, GCSFR, and STAT3 in 21 tissue biopsy samples and also in tumor associated normal tissue (TANT) samples derived from glioblastoma patients, which revealed significantly differential expression of these genes...
March 27, 2024: Scientific Reports
https://read.qxmd.com/read/38507932/saharan-dust-induces-the-lung-disease-related-cytokines-granulocyte-macrophage-colony-stimulating-factor-and-granulocyte-colony-stimulating-factor
#3
JOURNAL ARTICLE
Gerrit Bredeck, Jochen Dobner, Andrea Rossi, Roel P F Schins
Desert dust exposure is associated with adverse respiratory health effects. Desert dust is a complex pollutant mixtures that includes respirable crystalline and amorphous particles, metals, and microbial constituents. Given the health effects of desert dust and its heterogeneity, as yet unidentified harmful biological pathways may be triggered. Therefore, we exposed human in vitro air-liquid interface co-cultures of alveolar epithelial A549 cells and THP-1 macrophages to Saharan dust (SD). For comparison, we used the known pulmonary toxicant DQ12 quartz dust...
March 15, 2024: Environment International
https://read.qxmd.com/read/38498731/car19-monitoring-by-peripheral-blood-immunophenotyping-reveals-histology-specific-expansion-and-toxicity
#4
JOURNAL ARTICLE
Mark P Hamilton, Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani, Zachary Ehlinger, Shriya Syal, Zinaida Good, Brian Sworder, Joseph Schroers-Martin, Ying Lu, Lori Muffly, Robert S Negrin, Sally Arai, Robert Lowsky, Everett Meyer, Andrew R Rezvani, Judith A Shizuru, Wen-Kai Weng, Parveen Shiraz, Surbhi Sidana, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Bita Sahaf, David M Kurtz, Crystal L Mackall, Robert Tibshirani, Ash A Alizadeh, Matthew J Frank, David B Miklos
Chimeric antigen receptor (CAR) T cells directed against CD19 (CAR19) are a revolutionary treatment for B-cell lymphomas. CAR19 cell expansion is necessary for CAR19 function but is also associated with toxicity. To define the impact of CAR19 expansion on patient outcomes, we prospectively followed a cohort of 236 patients treated with CAR19 (brexucabtagene autoleucel or axicabtagene ciloleucel) for mantle cell (MCL), follicular (FL), and large B-cell lymphoma (LBCL) over the course of five years and obtained CAR19 expansion data using peripheral blood immunophenotyping for 188 of these patients...
March 18, 2024: Blood Advances
https://read.qxmd.com/read/38488686/favorable-outcome-of-non-myeloablative-allogeneic-transplantation-in-adult-patients-with-severe-sickle-cell-disease-a-single-center-experience-of-200-patients
#5
JOURNAL ARTICLE
Moussab Damlaj, Bader Alahmari, Ahmed Alaskar, Ayman Alhejazi, Husam Alsadi, Mazin Ahmed, Tahani Alanazi, Rasha Ahmed, Amani Alharbi, Inaam Shehabeddine, Afnan Alzaidi, Suha Alkhuraisat, Isam Mahassnah, Hamza Alquraan, Maybelle Ballili, Mohsen Alzahrani
Allogeneic hematopoietic stem cell transplant (HSCT) for adults with severe sickle cell disease (SCD) is potentially curative but not commonly utilized therapy due to complications such as graft failure (GF) and organ toxicity. Herein, we are reporting our long-term outcome data of non-myeloablative (NMA) HSCT in adults with severe SCD with emphasis on factors predicting event free survival (EFS). Adults with severe SCD undergoing NMA match-related donor allogeneic HSCT from 2015 to 2021 with at least 12 months of follow-up were included...
March 15, 2024: American Journal of Hematology
https://read.qxmd.com/read/38479049/comprehensive-analysis-of-multiple-cytokines-to-stratify-uropathogenic-escherichia-coli-pathogenesis-in-mouse-model-of-urinary-tract-infection
#6
JOURNAL ARTICLE
Snehashis Koley, Mandira Mukherjee
PURPOSE: Urinary tract infection (UTI) is one of the most common human bacterial infections primarily caused by uropathogenic E. coli (UPEC). Empiric treatment in UTI cause emergence of multidrug resistance and limit treatment options. Understanding UTI at the molecular level with respect to the causative pathogen as well as subsequent host response pose an absolute necessity towards appropriate clinical management. This study aimed to investigate host cytokine response in mouse UTI model with respect to bacterial colonization and associated virulence gene expression upon infection...
March 12, 2024: Cytokine
https://read.qxmd.com/read/38474265/gene-expression-of-csf3r-cd114-is-associated-with-poorer-patient-survival-in-glioma
#7
JOURNAL ARTICLE
Samir Ale Bark, Matheus Dalmolin, Osvaldo Malafaia, Rafael Roesler, Marcelo A C Fernandes, Gustavo R Isolan
Gliomas comprise most cases of central nervous system (CNS) tumors. Gliomas afflict both adults and children, and glioblastoma (GBM) in adults represents the clinically most important type of malignant brain cancer, with a very poor prognosis. The cell surface glycoprotein CD114, which is encoded by the CSF3R gene, acts as the receptor for the granulocyte colony stimulating factor (GCSF), and is thus also called GCSFR or CSFR. CD114 is a marker of cancer stem cells (CSCs), and its expression has been reported in several cancer types...
March 5, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38462875/comparison-of-steady-state-bone-marrow-and-gcsf-primed-stem-cell-sources-used-in-allogeneic-hematopoietic-stem-cell-transplantation
#8
JOURNAL ARTICLE
Hafiz Muhammad Nadeem, Asghar Ali, Nighat Shahbaz, Tariq Ghafoor, Tariq Azam Khattak, Qamar Un Nisa Chaudary
OBJECTIVE: To compare donor graft characteristics and clinical outcomes in recipients of allogeneic heamatopoietic stem cell transplantation (HSCT) using GCSF primed bone marrow (GBM) and steady-state bone marrow (SBM) as stem cell sources. STUDY DESIGN: Observational study. Place and Duration of the Study: Department of Clinical Haematology, Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan, from August 2018 to October 2020. METHODOLOGY: Eighty patients undergoing allogeneic HSCT were analysed...
March 2024: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/38452989/circulating-cytokines-and-vascular-dementia-a-bi-directional-mendelian-randomization-study
#9
JOURNAL ARTICLE
Yuge Xia, Zhirui Xu, Yicong Zhang, Dongli Jiang, Yunyi Zhu, Xiaolun Liang, Rui Sun
Inflammatory responses are associated with the development of vascular dementia (VaD). Circulating cytokines modulate the inflammatory response and are important for the immune system. To further elucidate the role of the immune system in VaD, we used Mendelian randomization (MR) to comprehensively and bi-directionally assess the role of circulating cytokines in VaD. Using state-of-the-art genome-wide association studies, we primarily assessed whether different genetic levels of 41 circulating cytokines affect the risk of developing VaD and, in turn, whether the genetic risk of VaD affects these circulating cytokines...
March 5, 2024: Experimental Gerontology
https://read.qxmd.com/read/38432021/mood-disturbances-in-newly-diagnosed-parkinson-s-disease-patients-reflect-intrathecal-inflammation
#10
JOURNAL ARTICLE
Mario Stampanoni Bassi, Luana Gilio, Giovanni Galifi, Fabio Buttari, Ettore Dolcetti, Antonio Bruno, Lorena Belli, Nicola Modugno, Roberto Furlan, Annamaria Finardi, Georgia Mandolesi, Alessandra Musella, Diego Centonze, Enrica Olivola
In Parkinson's disease (PD), neuroinflammation may be involved in the pathogenesis of mood disorders, contributing to the clinical heterogeneity of the disease. The cerebrospinal fluid (CSF) levels of interleukin (IL)-1β, IL-2, IL-6, IL-7, IL-8, IL-9, IL-12, IL-17, interferon (IFN)γ, macrophage inflammatory protein 1-alpha (MIP-1a), MIP-1b, granulocyte colony stimulating factor (GCSF), eotaxin, tumor necrosis factor (TNF), and monocyte chemoattractant protein 1 (MCP-1), were assessed in 45 newly diagnosed and untreated PD patients and in 44 control patients...
February 28, 2024: Parkinsonism & related Disorders
https://read.qxmd.com/read/38403877/determination-of-risk-factors-for-infectious-diarrhea-in-patients-with-hematological-malignancy
#11
JOURNAL ARTICLE
Şükran Şahinkaya, Zeynep Ture, Ali Unal, Gamze Kalın Ünüvar, Ayşegül Ulu Kılıç
BACKGROUND: The study aimed to determine the risk factors for infectious diarrhea in patients receiving chemotherapy or hematopoietic stem cell transplantation due to hematological malignancy. MATERIALS AND METHODS: This study was designed as a prospective observational study. Patients whose infectious agent was determined in laboratory examination were defined as having infectious diarrhea. Patients with diarrhea were categorized into infectious and unidentified, and compared regarding demographic data, treatments, risk factors, laboratory findings, and prognosis...
January 18, 2024: Infection & Chemotherapy
https://read.qxmd.com/read/38379291/peg-gcsf-induced-aortitis-in-a-patient-with-breast-cancer-distinguishing-between-infective-and-immune-mediated-aortitis
#12
JOURNAL ARTICLE
Luigi Zolio, Prudence A Francis, Nava Ferdowsi
No abstract text is available yet for this article.
February 20, 2024: Medical Journal of Australia
https://read.qxmd.com/read/38334336/blood-type-abo-and-the-cytokine-profile-of-follicular-fluid-in-women-undergoing-ivf-et
#13
JOURNAL ARTICLE
Rafal Adamczak, Natalia Ewa Ukleja-Sokołowska, Kinga Lis, Valentyna Chopyak, Anna Havrylyuk, Dagmara Adamczak, Wojciech Cnota, Zbigniew Bartuzi, Mariusz Dubiel
OBJECTIVES: ABO blood type was hypothesised to be related to a number of infertility processes. There is still an open debate on ABO blood group's incompatibility and infertility. It was associated with ovarian reserve in women with subfertility. There is still not enough information on the influence of blood type and the immunology of follicular fluid (FF). MATERIAL AND METHODS: 78 patients were selected, who underwent in vitro fertilization (IVF) between April 2021 and January 2022...
February 9, 2024: Ginekologia Polska
https://read.qxmd.com/read/38267304/real-world-evidence-of-triplet-therapy-in-metastatic-hormone-sensitive-prostate-cancer-an-austrian-multicenter-study
#14
JOURNAL ARTICLE
Mona Kafka, Giulia Giannini, Nastasiia Artamonova, Hannes Neuwirt, Heidemarie Ofner, Gero Kramer, Thomas Bauernhofer, Ferdinand Luger, Thomas Höfner, Wolfgang Loidl, Hubert Griessner, Lukas Lusuardi, Antonia Bergmaier, Andreas Berger, Thomas Winder, Sarah Weiss, Severin Bauinger, Steffen Krause, Martin Drerup, Elmar Heinrich, Magdalena Schneider, Stephan Madersbacher, Sonia Vallet, Franz Stoiber, Sarah Laimer, Stephan Hruby, Gert Schachtner, Udo Nagele, Sebastian Lenart, Anton Ponholzer, Jacob Pfuner, Clemens Wiesinger, Christoph Kamhuber, Ecan Müldür, Jasmin Bektic, Wolfgang Horninger, Isabel Heidegger
INTRODUCTION: Two randomized trials demonstrated a survival benefit of triplet therapy (androgen deprivation therapy [ADT]) plus androgen receptor pathway inhibitor [ARPI] plus docetaxel) over doublet therapy (ADT plus docetaxel), thus changing treatment strategies in metastatic hormonesensitive prostate cancer (mHSPC). PATIENTS AND METHODS: We conducted the first real-world analysis comprising 97 mHSPC patients from 16 Austrian medical centers, among them 79.4% of patients received abiraterone and 17...
January 4, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38146356/efficacy-and-safety-of-plerixafor-in-pediatric-cancer-patients-undergoing-peripheral-blood-stem-cell-harvest-for-autologous-hematopoietic-stem-cell-transplant
#15
JOURNAL ARTICLE
Aditya Kumar Gupta, Jagdish Prasad Meena, Hem Chandra Pandey, Poonam Coshic, Rachna Seth
Plerixafor for peripheral blood hematopoietic stem cell (PB HSC) mobilization in children undergoing autologous hematopoietic stem cell transplantation is primarily used following failure of the initial mobilization attempt. Data on plerixafor use in pediatric patients are limited. This retrospective study conducted at a single tertiary care center in India, details the efficacy and safety of plerixafor for 10 children with relapsed/refractory solid tumors or lymphomas. High risk neuroblastomas (HR NB) underwent autologous HSCT as part of consolidation...
August 25, 2023: Blood Cell Ther
https://read.qxmd.com/read/38054001/exploring-causal-correlations-between-inflammatory-cytokines-and-ankylosing-spondylitis-a-bidirectional-mendelian-randomization-study
#16
JOURNAL ARTICLE
Peng Fang, Xiaozhou Liu, Yang Qiu, Yang Wang, Dongsheng Wang, Jianning Zhao, Hao Ding, Nirong Bao
BACKGROUND: The impact of inflammatory factors on the development of Ankylosing Spondylitis (AS) is widely recognized, but the exact causal relationship remains unclear. METHODS: The bidirectional mendelian-randomization study utilized genetic data from a genome-wide association study (GWAS) of 186 AS cases and 456,162 controls of European ancestry. Inflammatory cytokines were obtained from a GWAS summary of 8,293 healthy participants. Causal associations were primarily investigated using the inverse variance-weighted method, supplemented by MR Egger, weighted median and weighted mode analyses...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38047054/phase-1-2-study-of-the-timing-and-efficacy-of-3%C3%A2-mg-peg-gcsf-in-neo-adjuvant-dose-dense-breast-cancer-treatment-protocols
#17
JOURNAL ARTICLE
Amol Patel, Abhishek Pathak, Arti Sarin, Divya Shelly, Richa Ranjan, Arashdeep Singh, Tripti Kala, Babitha Pv
Amol Patel Background  Peg-GCSF has similar efficacy at a dose of 60 µg/kg and 100 µg/kg. The conventional 6 mg SC dose was based on the maximum tolerable dose. In Japan, 3.6 mg dose was approved on the basis of dose finding studies. Peg-GCSF is an integral part of dose-dense chemotherapy protocols. Dose finding and scheduling study of peg-GCSF have not been conducted in Indian patients. Materials and Methods  We conducted two-center phase 1/2 clinical study addressing the timing and efficacy of peg-GCSF in Indian breast cancer patients (CTRI no: 2021/07/034751)...
July 2023: South Asian Journal of Cancer
https://read.qxmd.com/read/37946367/role-of-granulocyte-colony-stimulating-factor-in-the-treatment-of-cirrhosis-of-liver-a-systematic-review
#18
JOURNAL ARTICLE
Siddheesh Rajpurohit, Balaji Musunuri, Pooja Basthi Mohan, Ganesh Bhat, Shiran Shetty
OBJECTIVE: We performed a systematic review to analyze the benefits of and risk factors associated with granulocyte colony stimulating factor (GCSF) in patients with liver cirrhosis. METHODS: PubMed, Scopus, and Embase were searched for randomized controlled trials and case-control studies that compared the use of GCSF with another treatment or control group. The Jadad and Newcastle-Ottawa scales were used to assess the risk of bias in the included studies. The primary outcome studied was mortality; and the secondary outcomes were the disease severity score, liver transplantation criteria, complications, CD34+ cell count, adverse events, and health-related quality of life (HRQOL)...
November 2023: Journal of International Medical Research
https://read.qxmd.com/read/37932408/impact-of-the-immune-profiles-of-hypertensive-patients-with-and-without-obesity-on-covid-19-severity
#19
JOURNAL ARTICLE
Renata Moll-Bernardes, Juliana R Ferreira, Andréa Silvestre Sousa, Mariana B Tortelly, Adriana L Pimentel, Ana Cristina B S Figueiredo, Eduardo B Schaustz, José Carlos Pizzolante Secco, Allan Robson Kluser Sales, Flavia V O Terzi, Adriana Xavier de Brito, Renée O Sarmento, Marcia M Noya-Rabelo, Sergio Fortier, Flavia A Matos E Silva, Narendra Vera, Luciana Conde, Mauro Jorge Cabral-Castro, Denilson C Albuquerque, Paulo Rosado de-Castro, Gabriel C Camargo, Martha V T Pinheiro, Olga F Souza, Fernando A Bozza, Ronir R Luiz, Emiliano Medei
BACKGROUND: Comorbidities such as obesity, hypertension, and diabetes are associated with COVID-19 development and severity, probably due to immune dysregulation; however, the mechanisms underlying these associations are not clear. The immune signatures of hypertensive patients with obesity with COVID-19 may provide new insight into the mechanisms of immune dysregulation and progression to severe disease in these patients. METHODS: Hypertensive patients were selected prospectively from a multicenter registry of adults hospitalized with COVID-19 and stratified according to obesity (BMI ≥ 30 kg/m²)...
November 6, 2023: International Journal of Obesity
https://read.qxmd.com/read/37926362/humanin-ameliorates-tbi-related-cognitive-impairment-by-attenuating-mitochondrial-dysfunction-and-inflammation
#20
JOURNAL ARTICLE
Pavan Thapak, Zhe Ying, Victoria Palafox-Sanchez, Guanglin Zhang, Xia Yang, Fernando Gomez-Pinilla
Traumatic brain injury (TBI) often results in a reduction of the capacity of cells to sustain energy demands, thus, compromising neuronal function and plasticity. Here we show that the mitochondrial activator humanin (HN) counteracts a TBI-related reduction in mitochondrial bioenergetics, including oxygen consumption rate. HN normalized the disruptive action of TBI on memory function, and restored levels of synaptic proteins (synapsin 1 and p-CREB). HN also counteracted TBI-related elevations of pro-inflammatory cytokines in plasma (TNF-α, INF-y, IL 17, IL 5, MCP 5, GCSF, RANNETS, sTNFRI) as well as in the hippocampus (gp-130 and p-STAT3)...
November 3, 2023: Biochimica et Biophysica Acta. Molecular Basis of Disease
keyword
keyword
61561
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.